Order Article Reprints

Levati L, Bassi C, Mastroeni S, Lupini L, Antonini Cappellini GC, Bonmassar L, Alvino E, Caporali S, Lacal PM, Narducci MG, et al. Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with Targeted Therapy. Cancers. 2022; 14(15):3706. https://doi.org/10.3390/cancers14153706

Levati, Lauretta, Cristian Bassi, Simona Mastroeni, Laura Lupini, Gian Carlo Antonini Cappellini, Laura Bonmassar, Ester Alvino, Simona Caporali, Pedro Miguel Lacal, Maria Grazia Narducci, and et al. 2022. "Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with Targeted Therapy" Cancers 14, no. 15: 3706. https://doi.org/10.3390/cancers14153706

Levati, L., Bassi, C., Mastroeni, S., Lupini, L., Antonini Cappellini, G. C., Bonmassar, L., Alvino, E., Caporali, S., Lacal, P. M., Narducci, M. G., Molineris, I., De Galitiis, F., Negrini, M., Russo, G., & D’Atri, S. (2022). Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with Targeted Therapy. Cancers, 14(15), 3706. https://doi.org/10.3390/cancers14153706